{"id":"clm_0398CFEE2BD5","entity":"eli-lilly","predicate":"shares_outstanding","value":"1,103,843,444 shares","value_json":{"fp":"Q2","fy":2016,"accn":"0000059478-16-000399","form":"10-Q","filed":"2016-07-28","period":"Q2 FY2016","concept":"dei:EntityCommonStockSharesOutstanding"},"valid_from":"2016-07-18","valid_to":"2016-10-17","published":"2016-07-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Eli Lilly and Company shares outstanding: 1,103,843,444 shares\", as of 2016-07-18 (until 2016-10-17). Claim clm_0398CFEE2BD5, https://asof.is/claim/clm_0398CFEE2BD5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947816000399/0000059478-16-000399-index.htm.","url":"https://asof.is/claim/clm_0398CFEE2BD5","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_49EBF0007D5C","supersedes":["clm_29E5B3F2C398"],"first_seen_at":"2026-11-08T15:32:14.384194+00:00","updated_at":"2026-11-08T15:32:18.231201+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/59478/000005947816000399/0000059478-16-000399-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q2 FY2016","published_at":"2016-07-28T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2016, filed 2016-07-28"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}